Status:

UNKNOWN

Comparison of Histology From a Mesh Sponge and Traditional Esophageal Biopsies in Children and Adolescents With EoE

Lead Sponsor:

The Hospital for Sick Children

Conditions:

Eosinophilic Esophagitis

Eligibility:

All Genders

10-18 years

Phase:

NA

Brief Summary

The aim of the present study is determining the accuracy, safety and tolerance of the CytospongeTM (expandable sponge within a gelatin capsule attached to a string) relative to traditional upper endos...

Detailed Description

This is a cross-sectional study in pediatric subjects comparing histologic findings on esophageal biopsies obtained during upper GI endoscopies to histologic findings on tissue samples obtained throug...

Eligibility Criteria

Inclusion

  • Previous histologic diagnosis of eosinophilic esophagitis (symptoms of esophageal dysfunction and at least 15 eosinophils per high-power field on esophageal biopsy and after a comprehensive assessment of non-EoE disorders that could cause or potentially contribute to esophageal eosinophilia).1
  • Capable of swallowing a capsule 3 cm in length (trial with 3 cm jelly candy).
  • 10 to 18 years of age.
  • Male or female.
  • Able to give assent or consent.
  • Scheduled for an upper gastrointestinal endoscopy with biopsies on the same day to assess response to therapy and make decisions regarding further management.

Exclusion

  • Unable to swallow the capsule.
  • Unable to give assent or consent.
  • History of esophageal stricture on either upper gastrointestinal barium study or previous upper gastrointestinal endoscopy of food impaction that required removal.
  • History of portal hypertension or esophageal varices.
  • History of solid organ transplantation.
  • Known bleeding diathesis.
  • On anticoagulation therapy.
  • Known platelet count less than normal for age.
  • Pregnancy.
  • Need for intubation during endoscopy.
  • History of previous esophageal surgery.

Key Trial Info

Start Date :

April 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2023

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT05342168

Start Date

April 1 2022

End Date

September 1 2023

Last Update

April 22 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sickkids

Toronto, Ontario, Canada, M5G 1X8